Page last updated: 2024-08-24

atorvastatin and Acute Kidney Injury

atorvastatin has been researched along with Acute Kidney Injury in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (12.68)29.6817
2010's51 (71.83)24.3611
2020's11 (15.49)2.80

Authors

AuthorsStudies
Li, N; Xu, M; Yin, M; Zhao, G1
Gao, M; Jin, S; Tian, C; Yan, SX; Yang, TH1
Fomin, VV; Mironova, OI; Vasin, AA1
Li, CJ; Li, YJ; Su, BH; Yue, RZ; Zeng, R1
Avram, C; Baba, DF; Danilesco, A; Huma, L; Moldovan, DA; Rauta, RC; Sin, IA; Suciu, H1
Chatsudthipong, V; Cherngwelling, R; Jaikumkao, K; Lungkaphin, A; Pengrattanachot, N; Pongchaidecha, A; Swe, MT; Thongnak, L1
Chatsudthipong, V; Kongkaew, A; Lungkaphin, A; Thongnak, L1
Bellandi, F; Leoncini, M; Maioli, M; Toso, A; Tropeano, F; Villani, S1
Chen, H; Chen, J; Dai, Y; Duan, C; He, P; Huang, J; Huang, Z; Liu, Y; Shao, S; Tan, N; Xue, L; Yu, D; Zeng, L1
Alshogran, OY; Alzoubi, KH; El-Elimat, T; Nusair, SD; Obeidat, A; Sweidan, M1
Jiaqiong, L; Ming, L; Xiaoyong, L; Xinxue, L; Xuexian, T; Yan, L; Yinglan, L; Yue, G; Zena, H1
Aleta, M; Batra, J; Buttar, RS; Kreimerman, J; Melamed, ML1
Bei, WJ; Chen, JY; Chen, PY; Chen, SQ; Duan, C; Li, HL; Liu, Y; Tan, N; Wu, DX; Xie, NJ1
Huang, S; Su, B; Tao, Y; Yue, R; Zeng, J; Zeng, R; Zuo, C1
Billings, FT; Blume, JD; Linton, MF; Smith, DK; Smith, LE1
Fu, N; Liang, M; Yang, S1
Liu, LY; Liu, Y; Ma, FZ; Sun, YY; Wu, MY1
Akai, S; Matsubara, A; Oda, S; Tsuneyama, K; Yokoi, T1
Dalugama, C; Kularatne, SAM; Pathirage, M1
Chen, J; Dai, J; Mao, W; Qiu, Y; Wang, Z; Xu, H; Xu, X; Zhou, X1
Abdelfattah, S; Ahmad, Z; Hassan, SS; Motawie, A; Rizk, A; Thomann, C1
Mohamed, MFH; Saeed, AAM; Salameh, OK1
Chen, SM; Cheng, KJ; Imai, K; Lee, CM; Lee, JA; Lee, MC; Li, YC1
Liu, LY; Ma, FZ; Sun, T; Sun, YY; Wu, MY1
Chang, FC; Chen, JB; Chen, JH; Chen, JW; Chen, YL; Chen, YM; Huang, PH; Huang, TM; Ko, WJ; Kuo, YS; Liang, CJ; Lo, SC; Sun, CY; Wang, KC; Wu, KD; Wu, VC; Young, GH1
Dormuth, CR; Ernst, P; Garg, AX; Hemmelgarn, BR; James, MT; Lafrance, JP; Levy, A; Paterson, JM; Raymond, CB; Teare, GF1
Lei, W; Li, H; Tian, J; Wu, K1
Cai, W; Cao, Y; Chen, X; Li, S; Ma, W; Su, J; Wang, F; Zou, W1
Campese, VM1
Cong, H; Fu, N; Jin, D; Li, H; Li, X; Ma, H; Wang, Y1
Bellandi, F; Colonna, G; Di Sciascio, G; Grieco, D; Leoncini, M; Maioli, M; Patti, G; Toso, A1
Cannon, CP; de Lemos, J; Guo, J; Lewis, EF; Mega, JL; O'Donoghue, ML; Rouleau, JL; Sabatine, MS; Sarma, A1
Bangalore, S; DeMicco, DA; Fayyad, R; Hovingh, GK; Laskey, R; Vogt, L; Waters, DD1
Panchangam, V1
Cai, J; Ding, X; Fang, Y; Liu, S; Liu, T; Yu, X; Zhang, B; Zhang, H1
Horoshko, OM; Zamors'kyĭ, II; Zeleniuk, VH1
Choi, D; Hong, N; Kang, SM; Lee, SH; Oh, J; Park, S; Youn, JC1
Akiyama, E; Kimura, K; Kosuge, M1
Fang, M; Han, H; Li, D; Wang, H; Wu, H1
Hamza, M; Shehata, M1
Lewicki, M; Ng, I; Schneider, AG1
Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP1
Caran, T; Cibicek, N; Cibickova, L; Dobias, M; Ondra, P; Vorisek, V1
Dormanesh, B; Ghaznavi, H; Hosseini Tabatabaei, SM; Hosseinzadeh, A; Kamrava, SK; Mehrzadi, S; Motevalian, M1
Bellomo, R1
Billings, FT; Brown, NJ; Byrne, JG; Hendricks, PA; Petracek, MR; Schildcrout, JS; Shi, Y1
Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Jaikumkao, K; Lungkaphin, A; Pongchaidecha, A; Promsan, S1
Kwak, YL; Park, JH; Shim, JK; Soh, S; Song, JW1
Chen, J; He, X; Li, L; Tan, H; Zhou, Y1
Xu, G; Yang, P1
Billings, FT; Brown, NJ1
Chen, J; He, X; Li, L; Ran, P; Sun, S; Tan, H; Wu, Y; Yang, J; Zhou, Y1
Alexandropoulos, D; Arkadopoulos, N; Bazigos, GV; Doulamis, IP; Kondi-Pafiti, A; Konstantopoulos, P; Kotsis, T; Perrea, DN; Smyrniotis, V; Tragotsalou, N; Tzani, A1
Chen, GL; Su, JZ1
Amato, M; Bellandi, F; Gallopin, M; Leoncini, M; Maioli, M; Manzone, C; Micheletti, C; Tedeschi, D; Toso, A1
Alemdar, R; Aydin, M; Basar, C; Caglar, O; Erden, I; Ordu, S; Ozhan, H; Yalcin, S1
Bagshaw, SM; Bellomo, R; Cruz, DN; Gibney, N; Haase, M; Honore, PM; Joannes-Boyau, O; McAlister, FA; Palevsky, PM; Prowle, J; Ronco, C1
Abu-Fadel, MS; Pappy, R1
Bagshaw, SM; Bellomo, R; Calzavacca, P; Devarajan, P; Echeverri, JE; Haase, M; Haase-Fielitz, A; Licari, E; Ligabo, EV; Prowle, JR1
Cai, WQ; Chai, DJ; Chen, GL; Chen, XP; Huang, QY; Su, JZ; Wang, FB; Xue, Y; Zhang, DS1
Bacic-Vrca, V; Bozina, N; Horvatic, I; Lisicic, A; Marusic, S1
Enache, I; Garrouste, C; Heng, AE; Kaysi, S; Philipponnet, C; Tiple, A1
Bianco, A; Briguori, C; Colombo, A; Condorelli, G; De Micco, F; Donnarumma, E; Fiore, D; Focaccio, A; Golia, B; Quintavalle, C; Ricciardelli, B; Troncone, G; Visconti, G; Zabatta, MA1
Lewin, JJ; Nappi, JM; Taylor, MH1
Andreucci, M; Cianciaruso, B; Fuiano, G; Paternò, R; Pisani, A; Sabbatini, M; Serio, V; Serù, R; Uccello, F1
Satish, B; Unnikrishnan, D1
Jellinek, SP; Mahboobi, SK; Rose, M; Shohat, EZ1
Ho, L; Levidiotis, V; Lim, AK1
Ho, W; Huo, Y; Liu, ZP; Meng, L1
Johnson, A; Zager, RA1
Castro, JG; Gutierrez, L1

Reviews

9 review(s) available for atorvastatin and Acute Kidney Injury

ArticleYear
Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic

2018
Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis.
    Angiology, 2019, Volume: 70, Issue:4

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Cardiac Catheterization; Comparative Effectiveness Research; Contrast Media; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Risk Factors; Rosuvastatin Calcium; Treatment Outcome

2019
Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
    Clinical nephrology, 2019, Volume: 92, Issue:3

    Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Percutaneous Coronary Intervention

2019
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    BMJ (Clinical research ed.), 2013, Mar-18, Volume: 346

    Topics: Acute Kidney Injury; Adult; Aged; Atorvastatin; British Columbia; Cohort Studies; Confidence Intervals; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Safety; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Simvastatin; Sulfonamides; United Kingdom; United States

2013
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
    Clinical and experimental nephrology, 2014, Volume: 18, Issue:2

    Topics: Acute Kidney Injury; Atorvastatin; Disease Progression; Dyslipidemias; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney; Kidney Diseases; Male; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sulfonamides

2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
    The American journal of cardiology, 2014, Jun-15, Volume: 113, Issue:12

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Survival Analysis

2014
Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:2

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Contrast Media; Coronary Angiography; Creatinine; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Pyrroles; Randomized Controlled Trials as Topic

2015
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    The Cochrane database of systematic reviews, 2015, Mar-11, Issue:3

    Topics: Acute Kidney Injury; Adult; Atorvastatin; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Bypass; Creatinine; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Rosuvastatin Calcium; Simvastatin; Sulfonamides

2015
Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:10

    Topics: Acute Kidney Injury; Atorvastatin; Cardiovascular Diseases; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Risk; Rosuvastatin Calcium; Simvastatin

2015

Trials

14 trial(s) available for atorvastatin and Acute Kidney Injury

ArticleYear
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
    Cardiorenal medicine, 2020, Volume: 10, Issue:5

    Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Coronary Angiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Prospective Studies; Rosuvastatin Calcium

2020
High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.
    Journal of the American Heart Association, 2017, Dec-09, Volume: 6, Issue:12

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Atorvastatin; Cardiac Surgical Procedures; Cholesterol, HDL; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Postoperative Period; Preoperative Period; Risk Factors; Treatment Outcome

2017
High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.
    Angiology, 2018, Volume: 69, Issue:8

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; Contrast Media; Creatinine; Cystatin C; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Treatment Outcome

2018
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.
    Journal of the American Heart Association, 2014, May-01, Volume: 3, Issue:3

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pravastatin; Pyrroles

2014
Effect of high-dose statin loading on biomarkers related to inflammation and renal injury in patients hospitalized with acute heart failure. Randomized, controlled, open-label, prospective pilot study.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:10

    Topics: Acute Kidney Injury; Administration, Oral; Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Female; Heart Failure; Heptanoic Acids; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles

2014
Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:2

    Topics: Acute Kidney Injury; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Double-Blind Method; Egypt; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Protective Factors; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome

2015
High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    JAMA, 2016, Mar-01, Volume: 315, Issue:9

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aspartate Aminotransferases; Atorvastatin; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Postoperative Complications; Renal Insufficiency, Chronic

2016
Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial.
    Intensive care medicine, 2016, Volume: 42, Issue:9

    Topics: Acute Kidney Injury; Administration, Oral; Aged; Atorvastatin; Biomarkers; Cardiopulmonary Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Perioperative Period; Postoperative Complications; Prospective Studies

2016
[Atorvastatin attenuated contrast induced renal function damage].
    Zhonghua xin xue guan bing za zhi, 2009, Volume: 37, Issue:5

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Contrast Media; Coronary Angiography; Female; Heptanoic Acids; Humans; Male; Middle Aged; Pyrroles

2009
Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    The American journal of cardiology, 2010, Feb-01, Volume: 105, Issue:3

    Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Renal Insufficiency, Chronic; Risk Factors

2010
Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
    Angiology, 2010, Volume: 61, Issue:7

    Topics: Acetylcysteine; Acute Kidney Injury; Adult; Atorvastatin; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles

2010
Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery.
    Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:3

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Atorvastatin; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipocalin-2; Lipocalins; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Postoperative Complications; Proto-Oncogene Proteins; Pyrroles

2012
[Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Zhonghua xin xue guan bing za zhi, 2011, Volume: 39, Issue:9

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Contrast Media; Female; Heptanoic Acids; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles

2011
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.
    Circulation, 2012, Dec-18, Volume: 126, Issue:25

    Topics: Acetylcysteine; Acute Kidney Injury; Aged; Animals; Atorvastatin; Cells, Cultured; Contrast Media; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Middle Aged; Pyrroles; Tumor Suppressor Protein p53

2012

Other Studies

48 other study(ies) available for atorvastatin and Acute Kidney Injury

ArticleYear
Atorvastatin (ATV)-Loaded Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhance the Therapeutic Efficacy of Acute Kidney Injury.
    Journal of biomedical nanotechnology, 2021, Sep-01, Volume: 17, Issue:9

    Topics: Acute Kidney Injury; Atorvastatin; Humans; Hydrogen Peroxide; Lipid Bilayers; Nanoparticles; Silicon Dioxide

2021
The preventive effects of different doses of atorvastatin on contrast-induced acute kidney injury after CT perfusion.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Atorvastatin; Biomarkers; C-Reactive Protein; Contrast Media; Creatinine; Glomerular Filtration Rate; Humans; Interleukin-6; Perfusion; Tomography, X-Ray Computed

2022
[The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media].
    Terapevticheskii arkhiv, 2022, Oct-24, Volume: 94, Issue:9

    Topics: Acute Kidney Injury; Atorvastatin; Cardiovascular Diseases; Contrast Media; Creatinine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed

2022
Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
    BMC nephrology, 2023, 02-02, Volume: 24, Issue:1

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Caspases; Contrast Media; Epithelial Cells; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats; Signal Transduction; Toll-Like Receptor 4

2023
The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts-A Retrospective Single-Center Cohort Study.
    International journal of environmental research and public health, 2023, 02-16, Volume: 20, Issue:4

    Topics: Acute Kidney Injury; Atorvastatin; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus, Type 2; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Complications; Retrospective Studies

2023
Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation.
    Biochimica et biophysica acta. Molecular basis of disease, 2020, 06-01, Volume: 1866, Issue:6

    Topics: Acute Kidney Injury; Animals; Antioxidants; Atorvastatin; Diet, High-Fat; Humans; Inflammation; Insulin; Insulin Resistance; Kidney; Lipid Metabolism; Obesity; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Wistar

2020
Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat/high-fructose diet-induced insulin resistant rats.
    Toxicology and applied pharmacology, 2020, 06-01, Volume: 396

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Benzhydryl Compounds; Blotting, Western; Dietary Carbohydrates; Dietary Fats; Drug Therapy, Combination; Fatty Liver; Fructose; Glucosides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; Rats; Rats, Wistar

2020
Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 128

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; Contrast Media; Creatinine; Female; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Factors; Rosuvastatin Calcium; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome; Up-Regulation

2020
Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:7

    Topics: Acetylcysteine; Acute Kidney Injury; Animals; Atorvastatin; Contrast Media; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Therapy, Combination; Male; Rats; Rats, Sprague-Dawley; Ubiquinone

2021
Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide.
    Renal failure, 2020, Volume: 42, Issue:1

    Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; Contrast Media; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Hydrogen Sulfide; Inflammation; Kidney; Male; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Sulfides; Up-Regulation

2020
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.
    Journal of general internal medicine, 2017, Volume: 32, Issue:10

    Topics: Acute Kidney Injury; Aged, 80 and over; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis; Sitagliptin Phosphate; Vitamin D

2017
Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography.
    Medicine, 2017, Volume: 96, Issue:30

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Contrast Media; Coronary Angiography; Creatinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Protective Agents; Risk; Time Factors; Treatment Failure

2017
Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.
    Renal failure, 2017, Volume: 39, Issue:1

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Blood Urea Nitrogen; Contrast Media; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Kidney Tubules; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4

2017
Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin.
    Toxicology letters, 2018, Volume: 291

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Atorvastatin; Buthionine Sulfoximine; Ciprofloxacin; Creatine Kinase; Disease Models, Animal; Drug Interactions; Female; Glutathione Synthase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Rhabdomyolysis

2018
Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.
    Journal of medical case reports, 2018, May-22, Volume: 12, Issue:1

    Topics: Acute Kidney Injury; Adult; Atorvastatin; Creatinine; Cytochrome P-450 CYP2C8 Inhibitors; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Polypharmacy; Rhabdomyolysis; Risk Factors

2018
Preconditioning with atorvastatin against renal ischemia-reperfusion injury in nondiabetic versus diabetic rats.
    Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:1

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Diabetes Mellitus, Experimental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning; Kidney Cortex; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury

2019
Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death.
    The American journal of case reports, 2019, May-18, Volume: 20

    Topics: Acute Kidney Injury; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Fatal Outcome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis

2019
A novel preventive mechanism of gentamicin-induced nephrotoxicity by atorvastatin.
    Biomedical chromatography : BMC, 2019, Volume: 33, Issue:11

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Gentamicins; Kidney; Male; Oxidative Stress; Protective Agents; Rats; Rats, Wistar

2019
In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin.
    Angiogenesis, 2013, Volume: 16, Issue:3

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Animals; Apoptosis; Atorvastatin; Blotting, Western; Centrifugation, Density Gradient; Endothelial Cells; Female; Flow Cytometry; Gene Expression Regulation; Heptanoic Acids; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indican; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nitric Oxide Synthase Type III; Pyrroles; Reactive Oxygen Species; Stem Cells; Taiwan; Vascular Cell Adhesion Molecule-1

2013
Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats.
    BMC nephrology, 2014, Jan-15, Volume: 15

    Topics: Acute Kidney Injury; Animals; Anticholesteremic Agents; Atorvastatin; Disease Models, Animal; Glomerular Filtration Rate; Heptanoic Acids; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome

2014
Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Contrast Media; Diabetes Mellitus, Experimental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iohexol; Kidney Tubules; Male; Protein Phosphatase 1; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Rats; Rats, Wistar; rho-Associated Kinases

2014
Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.
    TheScientificWorldJournal, 2014, Volume: 2014

    Topics: Acute Kidney Injury; Aged; Antioxidants; Atorvastatin; Biomarkers; Contrast Media; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Function Tests; Male; Middle Aged; Perioperative Period; Probucol; Prospective Studies; Pyrroles; Risk Factors; Uric Acid

2014
Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    International journal of cardiology, 2014, Jun-15, Volume: 174, Issue:2

    Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Contrast Media; Disease-Free Survival; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Percutaneous Coronary Intervention; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides

2014
Statin-associated acute interstitial nephritis and rhabdomyolysis.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:3

    Topics: Acute Kidney Injury; Atorvastatin; Glucocorticoids; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nephritis, Interstitial; Prednisolone; Pyrroles; Renal Dialysis; Rhabdomyolysis; Time Factors; Treatment Outcome

2014
Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.
    American journal of nephrology, 2014, Volume: 39, Issue:6

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Graft Survival; Heptanoic Acids; HMGB1 Protein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Innate; Inflammation; Kidney; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Oxidative Stress; Pyrroles; Rats; Reperfusion Injury; Toll-Like Receptor 4

2014
[Renoprotective efficacy of different doses of statins in experimental acute renal failure].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2014, Volume: 60, Issue:2

    Topics: Acute Kidney Injury; Administration, Topical; Animals; Atorvastatin; Creatine Kinase; Diuresis; Glomerular Filtration Rate; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Lovastatin; Pyrroles; Rats; Rhabdomyolysis; Simvastatin; Stomach; Urodynamics

2014
Is high-dose statin loading effective for acute decompensated heart failure? Insight of inflammation and acute kidney injury.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:10

    Topics: Acute Kidney Injury; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrroles

2014
Multi-drug intoxication fatality involving atorvastatin: A case report.
    Forensic science international, 2015, Volume: 257

    Topics: Acute Kidney Injury; Aged; Alcoholics; Anthraquinones; Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; Drug Overdose; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Piperazines; Rhabdomyolysis; Suicide; Vasodilator Agents; Verapamil

2015
Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney.
    Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:3

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Creatinine; Drug Synergism; Gentamicins; Glutathione; Kidney; Kidney Function Tests; Male; Malondialdehyde; Melatonin; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Urea

2016
Perioperative Statins in Cardiac Surgery and Acute Kidney Injury.
    JAMA, 2016, Mar-01, Volume: 315, Issue:9

    Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male

2016
Atorvastatin improves renal organic anion transporter 3 and renal function in gentamicin-induced nephrotoxicity in rats.
    Experimental physiology, 2016, 06-01, Volume: 101, Issue:6

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Gentamicins; Kidney; Male; Organic Anion Transporters, Sodium-Independent; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2016
Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression.
    Journal of pharmacological sciences, 2016, Volume: 131, Issue:1

    Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Atorvastatin; Caspase 3; Cell Line; Contrast Media; Creatinine; Cytokines; HSP27 Heat-Shock Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iopamidol; JNK Mitogen-Activated Protein Kinases; Kidney; Male; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley

2016
Statins to Reduce Acute Kidney Injury After Cardiac Surgery.
    JAMA, 2016, Jul-19, Volume: 316, Issue:3

    Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male

2016
Statins to Reduce Acute Kidney Injury After Cardiac Surgery--Reply.
    JAMA, 2016, Jul-19, Volume: 316, Issue:3

    Topics: Acute Kidney Injury; Atorvastatin; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male

2016
Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro.
    Molecular medicine reports, 2017, Volume: 15, Issue:4

    Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; Cell Line; Contrast Media; HSP27 Heat-Shock Proteins; Humans; Iopamidol; Kidney; Male; Protective Agents; Rats; Up-Regulation

2017
Protective effects of N-acetylcystein and atorvastatin against renal and hepatic injury in a rat model of intestinal ischemia-reperfusion.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Atorvastatin; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestines; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury

2017
Recent trials in critical care nephrology.
    Contributions to nephrology, 2010, Volume: 165

    Topics: Acute Kidney Injury; Atorvastatin; Critical Care; Critical Illness; Decision Support Systems, Clinical; Evidence-Based Medicine; Female; Hemofiltration; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Male; Metabolic Clearance Rate; Middle Aged; Multicenter Studies as Topic; Pyrroles; Random Allocation; Randomized Controlled Trials as Topic; Renal Circulation; Renal Dialysis; Renal Replacement Therapy; Sepsis; Severity of Illness Index; Survival Rate

2010
Additional data supporting the use of statins to prevent contrast induced nephropathy.
    International journal of cardiology, 2011, Oct-20, Volume: 152, Issue:2

    Topics: Acute Kidney Injury; Atorvastatin; Contrast Media; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment

2011
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    International journal of clinical pharmacy, 2012, Volume: 34, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Kidney Injury; Aged; Aryl Hydrocarbon Hydroxylases; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pantoprazole; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Pyrroles; Renal Dialysis; Rhabdomyolysis; Risk Factors; Treatment Outcome

2012
Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
    Transplantation proceedings, 2012, Volume: 44, Issue:9

    Topics: Acute Kidney Injury; Atorvastatin; Colchicine; Cyclosporine; Drug Interactions; Gout; Gout Suppressants; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrroles; Quadriplegia; Rhabdomyolysis; Treatment Outcome

2012
Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:10

    Topics: Acute Disease; Acute Kidney Injury; Atorvastatin; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis

2002
Atorvastatin improves the course of ischemic acute renal failure in aging rats.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:4

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Kidney; Male; Pyrroles; Rats; Rats, Sprague-Dawley

2004
Exertion-induced rhabdomyolysis in a patient on statin therapy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:1

    Topics: Acute Kidney Injury; Atorvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipidemias; Long-Term Care; Male; Middle Aged; Physical Exertion; Pyrroles; Rhabdomyolysis; Risk Assessment; Severity of Illness Index

2005
Systemic infections can decrease the threshold of statin-induced muscle injury.
    Southern medical journal, 2006, Volume: 99, Issue:4

    Topics: Acute Kidney Injury; Aged, 80 and over; Atorvastatin; Bacteremia; Enterococcus faecalis; Escherichia coli; Heart Valve Prosthesis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscular Diseases; Pyrroles

2006
Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation.
    Internal medicine journal, 2006, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Anticholesteremic Agents; Atorvastatin; Disseminated Intravascular Coagulation; Drug Synergism; Female; Hemolytic-Uremic Syndrome; Heptanoic Acids; Humans; Middle Aged; Muscle Relaxants, Central; Pyrroles; Quinine; Rhabdomyolysis; Sleep-Wake Transition Disorders

2006
Clinical characteristics and outcomes of Chinese patients with cholesterol crystal embolism after coronary intervention.
    Clinical cardiology, 2006, Volume: 29, Issue:11

    Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Arteriosclerosis; Atorvastatin; China; Coronary Angiography; Embolism, Cholesterol; Female; Heptanoic Acids; Humans; Hypolipidemic Agents; Male; Prognosis; Prospective Studies; Pyrroles; Risk Assessment; Risk Factors; Simvastatin; Treatment Outcome

2006
Renal cortical cholesterol accumulation is an integral component of the systemic stress response.
    Kidney international, 2001, Volume: 60, Issue:6

    Topics: Acute Kidney Injury; Animals; Atorvastatin; Blotting, Western; Cell Line; Cholesterol; Cholesterol Esters; Escherichia coli Infections; Glycerol; Heptanoic Acids; Hot Temperature; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Cortex; Male; Mice; Mice, Inbred Strains; Pyrroles; Shock; Stress, Physiological

2001
Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
    The American journal of medicine, 2002, Apr-15, Volume: 112, Issue:6

    Topics: Acute Kidney Injury; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Delavirdine; Drug Interactions; Heptanoic Acids; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mixed Function Oxygenases; Pyrroles; Rhabdomyolysis

2002